16:10 EDT Acadia Pharmaceuticals (ACAD) files to sell 43.58M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- ACADIA Pharmaceuticals Reports Strong Q1 Earnings Growth
- Positive Outlook for ACADIA Pharmaceuticals: Buy Rating Affirmed Amid Strategic Growth Initiatives and Promising Pipeline Developments
- Positive Growth Outlook for ACADIA Pharmaceuticals Driven by Daybue’s Expanding Patient Base and Market Potential
- ACADIA Pharmaceuticals: Promising Growth with Strong Sales Projections and Strategic Advancements
- Positive Outlook for ACADIA Pharmaceuticals: Strong Financial Performance and Promising Pipeline Developments Justify Buy Rating